Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Experimental and Molecular Therapeutics 21: Cell Cycle Checkpoint and Kinase Inhibition

Induction of cyclin-kinase inhibitors p21Cip1 and p27Kip1 by chemopreventive isoprenoids perillyl alcohol, farnesol, and geraniol in human pancreatic adenocarcinoma cells.

Dean A. Wiseman and Pamela L. Crowell
Dean A. Wiseman
Indiana Univ./Purdue Univ. at Indianapolis, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela L. Crowell
Indiana Univ./Purdue Univ. at Indianapolis, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

2332

The isoprenoid drugs perillyl alcohol (POH), geraniol (GOH), and farnesol (FOH) have been previously demonstrated to have anticancer properties both in vitro and in vivo models of human pancreatic ductal adenocarcinoma. Furthermore, the anticancer effect in vitro occurs with an increase in levels of the cyclin-kinase inhibitor protein p27Kip1 and a simultaneous decrease in levels of Cyclin A protein. It was hypothesized that removing p27Kip1 protein from cells would cause resistance to the isoprenoid antiproliferative effect. RNA interference (RNAi) was used to reduce protein levels of p27Kip1 in MIA PaCa-2 human pancreatic ductal adenocarcinoma cells, thus mitigating its potential influence in cell response. Proliferation rates of transfected cells were compared to nontransfected controls following 24-hour exposure to isoprenoids (300, 500 μM POH; 200, 400 μM GOH; 60, 90 μM FOH). Following transfection of anti-p27Kip1 siRNA, and immediately prior to isoprenoid exposure, endogenous levels of p27Kip1 protein were <6% of nontransfected levels, with the downregulation lasting at least 72 hours following removal of transfection media. However, the proliferation rate of transfected cells demonstrated only modest resistance relative to nontransfected cells. RNAi caused a 17.5%, 20.32%, and 15.56% reduction in isoprenoid-induced growth inhibition in POH, GOH, and FOH, respectively. With this result, protein levels of p21Cip1 were examined in MIA PaCa-2 and BxPC-3 human ductal adenocarcinoma cells, following exposure for 24 hours of POH (300,500 μM), GOH (200,400 μM), and FOH (60, 90 μM). Protein levels were compared using Western analysis and normalized using β-actin. Significant increases (p < 0.05, n≥3) were observed in p21Cip1 protein levels for all three isoprenoids. Increases were 3.5 and 4.5 fold for POH (300, 500 μM), 3.86 and 5-fold for GOH (200,400 μM), and 3 and 4.21-fold for FOH (60,90 μM) These results suggest that these three drugs operate through a similar mechanism of action, mediated in part by a combination of the increased expression of both p27Kip1 and p21Cip1, resulting in cells undergoing G0/G1 arrest.

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Induction of cyclin-kinase inhibitors p21Cip1 and p27Kip1 by chemopreventive isoprenoids perillyl alcohol, farnesol, and geraniol in human pancreatic adenocarcinoma cells.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Induction of cyclin-kinase inhibitors p21Cip1 and p27Kip1 by chemopreventive isoprenoids perillyl alcohol, farnesol, and geraniol in human pancreatic adenocarcinoma cells.
Dean A. Wiseman and Pamela L. Crowell
Cancer Res April 1 2004 (64) (7 Supplement) 538-539;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction of cyclin-kinase inhibitors p21Cip1 and p27Kip1 by chemopreventive isoprenoids perillyl alcohol, farnesol, and geraniol in human pancreatic adenocarcinoma cells.
Dean A. Wiseman and Pamela L. Crowell
Cancer Res April 1 2004 (64) (7 Supplement) 538-539;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Small molecule inhibitors of CHK1 cause abrogation of the G2/M cell cycle checkpoint in vitro and tumor regression in a murine xenograft model.
  • Claspin, a Chk1 interacting protein, is involved in gemcitabine-induced S phase checkpoint activation.
Show more Experimental and Molecular Therapeutics 21: Cell Cycle Checkpoint and Kinase Inhibition
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement